present
studi
conduct
examin
whether
cellular
andor
viral
cholesterol
level
play
role
porcin
deltacoronaviru
pdcov
replic
result
show
deplet
cholesterol
cell
virion
treat
diminish
pdcov
infect
dosedepend
manner
addit
exogen
cholesterol
cell
virion
moder
restor
pdcov
infect
furthermor
pharmacolog
sequestr
cellular
viral
cholesterol
effici
block
viru
attach
intern
taken
togeth
current
data
indic
cholesterol
present
cell
membran
viral
envelop
contribut
pdcov
replic
act
key
compon
viral
entri
porcin
deltacoronaviru
pdcov
newli
discov
enter
coronaviru
associ
acut
enter
intestin
damag
piglet
envelop
singlestrand
positivesens
rna
viru
taxonom
belong
genu
deltacoronaviru
famili
coronavirida
order
nidoviral
viru
first
discov
pig
hong
kong
subsequ
report
us
china
south
korea
thailand
vietnam
sinc
pdcov
infect
result
sever
villou
atrophi
small
intestin
lead
wateri
diarrhea
vomit
dehydr
mortal
nurs
piglet
clinic
patholog
present
pdcov
indistinguish
swine
enter
diseas
caus
transmiss
gastroenter
viru
tgev
porcin
epidem
diarrhea
viru
pedv
appar
lower
mortal
affect
neonat
piglet
lipid
raft
membran
microdomain
enrich
cholesterol
sphingolipid
associ
protein
involv
process
viru
infect
cholesterol
essenti
compon
lipid
raft
play
import
role
variou
aspect
viru
life
cycl
especi
viral
entri
particular
success
entri
envelop
virus
includ
mani
coronavirus
requir
presenc
cholesterol
either
viral
cellular
membran
howev
potenti
relationship
cholesterol
pdcov
replic
remain
undetermin
therefor
studi
investig
necess
cholesterol
mechan
act
pdcov
infect
swine
testicl
st
cell
cultur
alpha
minimum
essenti
medium
invitrogen
carlsbad
ca
supplement
fetal
bovin
serum
fb
invitrogen
pdcov
strain
propag
st
cell
viru
growth
medium
supplement
antibioticantimycot
solut
mm
hepe
invitrogen
trypsin
describ
previous
watersolubl
cholesterol
purchas
sigma
st
loui
mo
dissolv
distil
water
dw
ethanol
respect
cytotox
effect
compound
st
cell
analyz
use
bromid
mtt
assay
sigma
describ
previous
pdcov
n
proteinspecif
monoclon
antibodi
mab
kdn
use
studi
describ
previous
st
cell
pretreat
dw
h
mock
infect
infect
pdcov
multipl
infect
cultiv
viru
growth
medium
supplement
vehicl
desir
concentr
unless
otherwis
indic
virusinfect
st
cell
analyz
immunofluoresc
assay
ifa
fluorescenceactiv
cell
sort
fac
describ
previous
cultur
supernat
also
collect
h
postinfect
hpi
pdcov
titer
measur
limit
dilut
st
cell
duplic
tissu
cultur
infecti
dose
tcid
per
ml
calcul
describ
previous
cholesterol
replenish
st
cell
first
preincub
vehicl
dw
variou
final
concentr
h
supplement
exogen
cholesterol
vv
ethanol
vehicl
control
cell
cultur
medium
h
inocul
pdcov
parallel
cellular
cholesterol
content
determin
use
cholesterol
cellbas
detect
assay
kit
cayman
chemic
ann
arbor
mi
accord
manufactur
instruct
remov
cholesterol
viral
membran
viral
suspens
treat
variou
concentr
h
follow
ultracentrifug
remov
describ
previous
cholesterol
replenish
viru
suspens
mock
treat
treat
h
supplement
without
exogen
cholesterol
h
follow
ultracentrifug
describ
previous
addit
virion
cholesterol
content
determin
fluoresc
intens
analysi
use
filipin
iii
cayman
chemic
spark
multimod
micropl
reader
tecan
switzerland
describ
previous
statist
analys
perform
use
student
test
pvalu
less
consid
statist
signific
accord
result
mtt
assay
none
dose
cholesterol
employ
present
studi
advers
effect
cell
viabil
supplementari
fig
st
cell
pretreat
concentr
mm
dw
vehicl
control
h
prior
infect
viral
product
initi
measur
monitor
cytopath
effect
cpe
later
confirm
ifa
use
antin
protein
mab
cholesterolsequest
compound
dramat
reduc
virusinduc
cpe
express
pdcov
gene
dosedepend
manner
supplementari
fig
base
quantif
n
protein
stain
result
proport
virusinfect
cell
notic
attenu
treatment
approxim
maximum
inhibit
virus
respons
applic
mm
fig
treat
cell
mm
hpi
also
result
approxim
decreas
pdcov
product
wherea
exposur
compound
hpi
signific
inhibitori
effect
infect
compar
control
level
supplementari
fig
result
demonstr
must
present
preinfect
earli
stage
viral
infect
exert
antivir
effect
cellular
cholesterol
deplet
reagent
also
determin
viral
yield
pharmacolog
deplet
cellular
cholesterol
illustr
fig
inhibit
growth
viral
progeni
dosedepend
manner
peak
viral
titer
vehicletr
control
tcid
ml
vehicletr
control
wherea
addit
mm
reduc
titer
pdcov
tcid
ml
repres
reduct
compar
control
level
taken
togeth
data
indic
deplet
cholesterol
target
cell
effici
suppress
pdcov
replic
next
examin
whether
cholesterol
replenish
restor
pdcov
infect
cell
addit
exogen
cholesterol
virusinfect
cell
significantli
revers
antivir
activ
although
incub
alon
greatli
reduc
pdcov
product
concentr
mm
mm
respect
supplement
exogen
cholesterol
significantli
increas
pdcov
product
respect
concentr
fig
consist
cholesterol
replenish
result
increas
viru
yield
compar
vehicl
control
fig
verifi
import
cellular
cholesterol
investig
alter
cellular
cholesterol
content
cell
treat
absenc
presenc
exogen
cholesterol
use
filipin
iii
fluoresc
polyen
antibiot
bind
cholesterol
accord
lower
intens
cpe
cellular
cholesterol
level
specif
decreas
virusinfect
cell
compar
virusinfect
nontreat
cell
supplement
exogen
cholesterol
markedli
elev
cholesterol
level
cpe
product
virusinfect
cell
fig
altogeth
data
reveal
cellular
cholesterol
play
pivot
role
pdcov
infect
analyz
whether
virionassoci
cholesterol
requir
pdcov
infect
viru
mocktreat
treat
concentr
mm
prior
inocul
infect
investig
use
virolog
method
similar
less
effect
mm
effect
cellular
cholesterol
deplet
remov
cholesterol
virion
result
signific
reduct
replic
pdcov
reduct
almost
highest
concentr
use
fig
supplementari
fig
furthermor
pdcov
titer
reduc
tcid
ml
follow
treatment
viru
mm
repres
reduct
compar
control
level
fig
verifi
whether
effect
virion
cholesterol
deplet
revers
exogen
cholesterol
ad
viral
suspens
pretreat
pdcov
infect
decreas
presenc
alon
mm
wherea
viru
product
increas
concentr
exogen
cholesterol
ad
fig
consequ
reduc
viral
titer
follow
treatment
restor
valu
close
observ
vehicletr
virusinfect
cell
fig
confirm
result
measur
content
viral
cholesterol
follow
treatment
alon
follow
treatment
cholesterol
replenish
shown
fig
viral
cholesterol
level
significantli
reduc
virus
compar
vehicletr
virus
howev
exogen
cholesterol
restor
cholesterol
valu
viral
membran
close
determin
prior
treatment
result
reveal
cholesterol
content
cell
membran
viral
envelop
relev
pdcov
infect
vitro
determin
point
pharmacolog
deplet
cellular
viral
cholesterol
directli
influenc
pdcov
entri
assess
two
stage
viral
entri
attach
penetr
use
bind
intern
assay
treatment
target
cell
virion
describ
previous
treat
cell
maintain
permit
viral
bind
prevent
intern
shown
fig
pdcov
titer
reduc
dosedepend
manner
cell
indic
cellular
cholesterol
deplet
inhibit
attach
viru
cell
moreov
pdcov
product
diminish
cell
incub
enabl
viru
entri
proceed
impli
cholesterol
sequestr
disturb
intern
pdcov
similarli
remov
cholesterol
viral
envelop
neg
affect
viral
adsorpt
postadsorpt
step
fig
taken
togeth
data
demonstr
pharmacolog
sequestr
cholesterol
hinder
viral
attach
subsequ
penetr
presenc
cholesterol
cell
membran
viral
envelop
indispens
pdcov
entri
process
conclus
find
indic
optim
infect
pdcov
requir
cholesterol
cell
membran
viru
envelop
critic
entri
pdcov
mani
coronavirus
exploit
cholesterol
present
viral
envelop
andor
cell
membran
maxim
viru
entri
cellular
cholesterol
essenti
entri
coronavirus
includ
mous
hepat
viru
sever
acut
respiratori
syndrom
coronaviru
human
coronaviru
avian
infecti
bronchiti
viru
type
ii
felin
coronaviru
fcov
pedv
howev
pdcov
present
studi
canin
coronaviru
type
fcov
tgev
consid
previou
present
studi
cholesterol
depend
infect
differ
among
coronavirus
pdcov
receptor
yet
identifi
unabl
examin
whether
cholesterol
depend
quantit
relat
presenc
hithertounidentifi
receptor
futur
research
address
question
whether
cholesterol
facilit
pdcov
entri
interact
viral
spike
protein
cellular
receptor
nevertheless
propos
cellular
viral
cholesterol
key
player
attach
penetr
stage
pdcov
entri
howev
cholesterol
deplet
cell
viru
consist
result
reduct
elimin
viral
infect
indic
viral
entri
may
occur
low
level
cholesterol
increas
cholesterol
content
part
make
process
effici
although
analysi
elucid
mechan
cholesterol
promot
pdcov
entri
assum
cholesteroldepend
viral
entri
close
connect
maintain
lipid
raft
structur
andor
biolog
membran
fluiditi
imped
viru
entri
viabl
antivir
strategi
like
act
extracellular
target
therebi
limit
cell
damag
therefor
pdcov
could
use
surrog
model
test
emerg
coronaviru
antivir
therapi
sinc
treatment
vaccin
current
avail
pdcov
result
present
indic
molecul
disrupt
viral
andor
cell
cholesterol
interfer
cholesterol
function
viral
entri
may
provid
excel
therapeut
option
treatment
coronaviru
infect
human
anim
